Compound heterozygous and homozygous mutations in ISPD have been associated with a broad clinical spectrum ranging from mild LGMD to a more severe Walker-Warburg syndrome [47], with the mutations predicted to be deleterious to protein function. The gene discussed is CRPPA; the disease is muscular dystrophy-dystroglycanopathy, type A.